Sarepta Therapeutics Inc (SRPT) Stock: Surpassing Expectations in the Market?
RBC Capital Mkts has recently raised Sarepta Therapeutics Inc (SRPT) stock to Outperform rating, as announced on July 29, 2024, according to Finviz. Earlier, on June 26, 2024, Citigroup had reduced the stock from a Buy to Neutral, setting a price target of $176. for SRPT stock. Piper Sandler also initiated Overweight rating with a […]
Sarepta Therapeutics Inc (SRPT) Stock Rated Outperform by RBC Capital Mkts
RBC Capital Mkts has recently raised Sarepta Therapeutics Inc (SRPT) stock to Outperform rating, as announced on July 29, 2024, according to Finviz. Earlier, on June 26, 2024, Citigroup had reduced the stock from a Buy to Neutral, setting a price target of $176. for SRPT stock. Piper Sandler also initiated Overweight rating with a […]
Why Is Sarepta Therapeutics Inc (SRPT) Stock Lagging Behind -0.97% from Its 50-Day SMA?
RBC Capital Mkts has recently raised Sarepta Therapeutics Inc (SRPT) stock to Outperform, as announced on July 29, 2024 according to Finviz. Earlier, on June 26, 2024, Citigroup had reduced the stock from a Buy to Neutral, setting a price target of $176 for SRPT stock. Piper Sandler also initiated Overweight rating with a price […]
How Does Sarepta Therapeutics Inc (SRPT) Stack Up Against Its Industry Peers?
RBC Capital Mkts has recently raised Sarepta Therapeutics Inc (SRPT) stock to Outperform, as announced on July 29, 2024 according to Finviz. Earlier, on June 26, 2024, Citigroup had reduced the stock from a Buy to Neutral, setting a price target of $176 for SRPT stock. Piper Sandler also initiated Overweight rating with a price […]
Sarepta Therapeutics Inc (NASDAQ:SRPT) Stock Price Advanced 1.24% to $144.01
RBC Capital Mkts raised the price target for the Sarepta Therapeutics Inc (NASDAQ:SRPT) stock from “a Sector perform” to “an Outperform”. The rating was released on July 29, 2024, according to finviz. We previously noted in another research note published on June 26, 2024 by Citigroup that downgraded the stock from a Buy to a […]
The Sarepta Therapeutics Inc (SRPT) Stock expansion path ahead
Citigroup raised the price target for the Sarepta Therapeutics Inc (NASDAQ:SRPT) stock from “a Buy” to “a Neutral”. The rating was released on June 26, 2024, according to finviz. The research report from RBC Capital Mkts has downgraded the stock from Outperform to Sector Perform, with a price target set at $142. The stock was […]
What is Sarepta Therapeutics Inc’s (SRPT) Stock Real Technical Picture?
Citigroup raised the price target for the Sarepta Therapeutics Inc (NASDAQ:SRPT) stock from “a Buy” to “a Neutral”. The rating was released on June 26, 2024, according to finviz. The research report from RBC Capital Mkts has downgraded the stock from Outperform to Sector Perform, with a price target set at $142. The stock was […]
In the current cycle, Sarepta Therapeutics Inc (SRPT) Stock is showing signs of growth
Citigroup raised the price target for the Sarepta Therapeutics Inc (NASDAQ:SRPT) stock from “a Buy” to “a Neutral”. The rating was released on June 26, 2024, according to finviz. The research report from RBC Capital Mkts has downgraded the stock from Outperform to Sector Perform, with a price target set at $142. The stock was […]
Sarepta Therapeutics Inc (SRPT) Stock is Just Right Size-Neither Too Big Nor Too Small
Citigroup raised the price target for the Sarepta Therapeutics Inc (NASDAQ:SRPT) stock from “a Buy” to “a Neutral”. The rating was released on June 26, 2024, according to finviz. The research report from RBC Capital Mkts has downgraded the stock from Outperform to Sector Perform, with a price target set at $142. The stock was […]
Getting Ready for the Bounce: Sarepta Therapeutics Inc (SRPT) Stock
Piper Sandler raised the price target for the Sarepta Therapeutics Inc (NASDAQ:SRPT) stock to “an Overweight”. The rating was released on May 31, 2024, according to finviz. We previously noted in another research note published on May 28, 2024 by RBC Capital Mkts that downgraded the stock from an Outperform to a Sector perform with […]
